| Date | Price Target | Rating | Analyst |
|---|---|---|---|
| 5/14/2025 | $83.00 | Outperform | RBC Capital Mkts |
| 3/26/2025 | $80.00 | Overweight | Wells Fargo |
| 3/24/2025 | $82.00 | Overweight | Morgan Stanley |
| 1/7/2025 | $38.00 → $70.00 | Equal Weight → Overweight | Barclays |
| 1/6/2025 | $60.00 → $70.00 | Neutral → Outperform | Robert W. Baird |
| 8/19/2024 | $41.00 → $36.00 | Overweight → Neutral | Piper Sandler |
| 8/15/2024 | $39.00 | Neutral → Buy | UBS |
| 8/8/2024 | Neutral → Buy | Guggenheim | |
| 8/8/2024 | $50.00 → $47.00 | Buy | TD Cowen |
| 5/10/2024 | $33.00 → $46.00 | Hold → Buy | TD Cowen |
8-K - Dutch Bros Inc. (0001866581) (Filer)
8-K - Dutch Bros Inc. (0001866581) (Filer)
8-K - Dutch Bros Inc. (0001866581) (Filer)
8-K - Dutch Bros Inc. (0001866581) (Filer)
SCHEDULE 13G - Dutch Bros Inc. (0001866581) (Subject)
DEFA14A - Dutch Bros Inc. (0001866581) (Filer)
DEF 14A - Dutch Bros Inc. (0001866581) (Filer)
8-K - Dutch Bros Inc. (0001866581) (Filer)
S-8 - Dutch Bros Inc. (0001866581) (Filer)
10-K - Dutch Bros Inc. (0001866581) (Filer)